Schrodinger Inc
NASDAQ:SDGR
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
16.98
37.21
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SDGR stock under the Base Case scenario is 15.15 USD. Compared to the current market price of 21.23 USD, Schrodinger Inc is Overvalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Schrodinger Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SDGR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Schrodinger Inc
Balance Sheet Decomposition
Schrodinger Inc
Current Assets | 456.4m |
Cash & Short-Term Investments | 388.7m |
Receivables | 44.8m |
Other Current Assets | 22.9m |
Non-Current Assets | 212.9m |
Long-Term Investments | 65.2m |
PP&E | 137.7m |
Intangibles | 4.8m |
Other Non-Current Assets | 5.2m |
Current Liabilities | 111.1m |
Accounts Payable | 11.2m |
Accrued Liabilities | 58.1m |
Other Current Liabilities | 41.8m |
Non-Current Liabilities | 108.8m |
Other Non-Current Liabilities | 108.8m |
Earnings Waterfall
Schrodinger Inc
Revenue
|
193.3m
USD
|
Cost of Revenue
|
-67.8m
USD
|
Gross Profit
|
125.5m
USD
|
Operating Expenses
|
-343.7m
USD
|
Operating Income
|
-218.2m
USD
|
Other Expenses
|
40.6m
USD
|
Net Income
|
-177.6m
USD
|
Free Cash Flow Analysis
Schrodinger Inc
USD | |
Free Cash Flow | USD |
SDGR Profitability Score
Profitability Due Diligence
Schrodinger Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Schrodinger Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
SDGR Solvency Score
Solvency Due Diligence
Schrodinger Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
Schrodinger Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SDGR Price Targets Summary
Schrodinger Inc
According to Wall Street analysts, the average 1-year price target for SDGR is 32.08 USD with a low forecast of 25.25 USD and a high forecast of 52.5 USD.
Dividends
Current shareholder yield for SDGR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. The company is headquartered in New York City, New York and currently employs 664 full-time employees. The company went IPO on 2020-02-06. The firm operates through two segments: Software and Drug Discovery. The Software segment is focused on licensing the Company’s software for molecular discovery. The Drug Discovery segment is focused on building a portfolio of preclinical and clinical drug programs, internally and through collaborations. The Company’s physics-based software platform enables discovery of molecules for drug development and materials applications. Its software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories. The Company’s pipeline includes CDC7, Wee1, MALT1, HIF-2 alpha and SOS1/KRAS. Its CDC7 is a small molecule inhibitor for treatment of solid and liquid tumors.
Contact
IPO
Employees
Officers
The intrinsic value of one SDGR stock under the Base Case scenario is 15.15 USD.
Compared to the current market price of 21.23 USD, Schrodinger Inc is Overvalued by 29%.